Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selection - Top-Institutions - MDSpire

Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selection

  • By

  • Brigida Anna Maiorano

  • Linda Cerbone

  • Carlo Messina

  • Pasquale Rescigno

  • Giandomenico Roviello

  • May 6, 2026

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Genitourinary Cancer

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Precision Medicine

  • #3

    Weill Cornell Medicine
    Weill Cornell Medicine

    New York, New York

    Key Differentiators

    • Oncology
    • Genitourinary Cancer

  • #4

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology
    • Cancer Research

  • #5

    City of Hope Comprehensive Cancer Center
    City of Hope Comprehensive Cancer Center

    Duarte, California

    Key Differentiators

    • Oncology
    • Translational Research

Original Source(s)

Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selection

  • by Brigida Anna Maiorano, Linda Cerbone, Carlo Messina, Pasquale Rescigno, Giandomenico Roviello

  • May 6, 2026

Related Content